Zachary Elliott, PharmD, MBA , Director, Fingerpaint Market Access
Advertisement
Articles by Zachary Elliott, PharmD, MBA , Director, Fingerpaint Market Access
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Angelini Pharma Enters $ 4.1 Billion Agreement to Acquire Catalyst Pharmaceuticals
2
Pharma M&A Roundup: Bayer to Acquire Perfuse Therapeutics, Madrigal Enters Licensing Agreement for ARO-PNPLA3
3
From Insight to Impact: Making Real-World Evidence Actionable in Urology
4
Pharmaceutical Executive Daily: Zentalis Doses First Patient with Azenosertib in Phase III Trial
5